Here, we investigated a N-terminal fragment of the tau protein (NT1) measured in plasma as a potential predictor of future cognitive decline, neurodegeneration, tau accumulation, and the development of MCI or AD in clinically normal elderly. The gene discussed is MAPT; the disease is Alzheimer disease.